Metraipolis › archive › dc_bc90455ef21f

Effect of an Arsenic Mitigation Program on Arsenic Exposure in American Indian Communities: A Cluster Randomized Controlled Trial of the Community-Led Strong… — Europe PMC PMID:38534131

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38534131
DOI
10.1289/ehp12548
License (as archived)
CC0-1.0
Archived
2026-10-06T20:06:18.688Z
SHA-256 of the archived text
49fc3feeea7f5ec6b07928be14db61ac37fda1e524a80311ebf617c0839dafba
Stable URL of this page
https://metraipolis.com/documento/dc_bc90455ef21f

How to cite

Effect of an Arsenic Mitigation Program on Arsenic Exposure in American Indian Communities: A Cluster Randomized Controlled Trial of the Community-Led Strong… — Europe PMC PMID:38534131 — Europe PMC (en), https://europepmc.org/article/MED/38534131 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_bc90455ef21f (Metraipolis archive dc_bc90455ef21f, sha256 49fc3feeea7f5ec6b07928be14db61ac37fda1e524a80311ebf617c0839dafba)
BibTeX
@misc{dcbc90455ef21f,
  title = {Effect of an Arsenic Mitigation Program on Arsenic Exposure in American Indian Communities: A Cluster Randomized Controlled Trial of the Community-Led Strong… — Europe PMC PMID:38534131},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38534131},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_bc90455ef21f; sha256 49fc3feeea7f5ec6b07928be14db61ac37fda1e524a80311ebf617c0839dafba},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/38534131. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Chronic arsenic exposure has been associated with an increased risk of cardiovascular disease; diabetes; cancers of the lung, pancreas and prostate; and all-cause mortality in American Indian communities in the Strong Heart Study. Objective: The Strong Heart Water Study (SHWS) designed and evaluated a multilevel, community-led arsenic mitigation program to reduce arsenic exposure among private well users in partnership with Northern Great Plains American Indian Nations. Methods: A cluster randomized controlled trial (cRCT) was conducted to evaluate the effectiveness of the SHWS arsenic mitigation program over a 2-y period on a ) urinary arsenic, and b ) reported use of arsenic-safe water for drinking and cooking. The cRCT compared the installation of a point-of-use arsenic filter and a mobile Health (mHealth) program (3 phone calls; SHWS mHealth and Filter arm) to a more intensive program, which included this same program plus three home visits (3 phone calls and 3 home visits; SHWS Intensive arm). Results: A 47% reduction in urinary arsenic [geometric mean (GM)=13.2 to 7.0μg/g creatinine] was observed from baseline to the final follow-up when both study arms were combined. By treatment arm, the reduction in urinary arsenic from baseline to the final follow-up visit was 55% in the mHealth and Filter arm (GM=14.6 to 6.55μg/g creatinine) and 30% in the Intensive arm (GM=11.2 to 7.82μg/g creatinine). There was no significant difference in urinary arsenic levels by treatment arm at the final follow-up visit comparing the Intensive vs. mHealth and Filter arms: GM ratio of 1.21 (95% confidence interval: 0.77, 1.90). In both arms combined, exclusive use of arsenic-safe water from baseline to the final follow-up visit significantly increased for water used for cooking (17% to 53%) and drinking (12% to 46%). Discussion: Delivery of the interventions for the community-led SHWS arsenic mitigation program, including the installation of a point-of-use arsenic filter and a mHealth program on the use of arsenic-safe water (calls only, no home visits), resulted in a significant reduction in urinary arsenic and increases in reported use of arsenic-safe water for drinking and cooking during the 2-y study period. These results demonstrate that the installation of an arsenic filter and phone calls from a mHealth program presents a promising approach to reduce water arsenic exposure among private well users. https://doi.org/10.1289/EHP12548.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: Environmental health perspectives, 2024 (prima pubblicazione 2024-03-27).
Identificativi: PMID 38534131 · PMCID PMC10967367 · DOI 10.1289/ehp12548.
Descrittori MeSH principali: Arsenic; Drinking Water.
Pagina: https://europepmc.org/article/MED/38534131 — https://doi.org/10.1289/ehp12548. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-06T18:30:56.424Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.